Deutsche Bank
NUVB icon

Deutsche Bank’s Nuvation Bio NUVB Stock Holding History

Deutsche Bank’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
269,620
+56,865
+27% +$278K ﹤0.01% 2068
2026
Q1 		$913K Buy
212,755
+21,938
+11% +$122K ﹤0.01% 2248
2025
Q4 		$1.71M Buy
190,817
+55,374
+41% +$343K ﹤0.01% 1879
2025
Q3 		$501K Buy
135,443
+23,203
+21% +$63.2K ﹤0.01% 2540
2025
Q2 		$219K Sell
112,240
-26,915
-19% -$56.1K ﹤0.01% 2914
2025
Q1 		$245K Sell
139,155
-15,945
-10% -$36.3K ﹤0.01% 2860
2024
Q4 		$413K Buy
155,100
+56,931
+58% +$147K ﹤0.01% 2714
2024
Q3 		$225K Buy
98,169
+25,840
+36% +$78.8K ﹤0.01% 2875
2024
Q2 		$211K Sell
72,329
-13,530
-16% -$41.3K ﹤0.01% 2774
2024
Q1 		$313K Buy
85,859
+4,193
+5% +$8.05K ﹤0.01% 2581
2023
Q4 		$123K Sell
81,666
-3,093
-4% -$3.98K ﹤0.01% 3126
2023
Q3 		$114K Buy
84,759
+16,351
+24% +$27.2K ﹤0.01% 3103
2023
Q2 		$123K Sell
68,408
-1,988
-3% -$3.38K ﹤0.01% 3177
2023
Q1 		$117K Sell
70,396
-5,174
-7% -$10.5K ﹤0.01% 3258
2022
Q4 		$145K Buy
75,570
+28,315
+60% +$57.3K ﹤0.01% 3144
2022
Q3 		$106K Sell
47,255
-17,631
-27% -$50.3K ﹤0.01% 3288
2022
Q2 		$210K Sell
64,886
-36,599
-36% -$160K ﹤0.01% 3130
2022
Q1 		$534K Sell
101,485
-6,091
-6% -$34.2K ﹤0.01% 2710
2021
Q4 		$914K Buy
107,576
+61,889
+135% +$569K ﹤0.01% 2489
2021
Q3 		$454K Buy
45,687
+20,257
+80% +$184K ﹤0.01% 3104
2021
Q2 		$236K Buy
+25,430
New +$290K ﹤0.01% 3693

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Deutsche Bank's NUVB Position: Q2 2026 in Review

Deutsche Bank increased its Nuvation Bio (NUVB) stake by 27% in Q2 2026, buying an estimated $278K and bringing the position to 269,620 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

Deutsche Bank first reported a position in NUVB in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.71M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Deutsche Bank held 269,620 shares of Nuvation Bio worth $1.53M as of Q2 2026.
  • Deutsche Bank bought 56,865 Nuvation Bio shares in Q2 2026, an estimated $278K.
  • Nuvation Bio made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2068 holding.
  • Deutsche Bank first reported a position in Nuvation Bio in Q2 2021 and has held it in 21 quarters since.
  • Deutsche Bank's Nuvation Bio position peaked at $1.71M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.